We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Depomed Says Teva Unit Infringed Diabetes Patents

Law360 (September 25, 2007, 12:00 AM EDT) -- Pharmaceutical company Depomed Inc. has asked a California court for summary judgment in a case accusing a Teva Pharmaceutical Industries Ltd. subsidiary of infringing two patents related to the diabetes drug...
To view the full article, register now.